The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

LUFIRONIL     N,N'-bis(2- methoxyethyl)pyridine-2,4...

Synonyms: Lufironilo, Lufironilum, Hoe-077, SureCN344625, CHEMBL2106793, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of HOE 077

  • The effect of a newly synthesized prolyl4-hydroxylase (PH) inhibitor, HOE 077 (pyridine-2, 4-di-carboxylic-di(2-methoxyethyl)amide), was examined using the model of choline-deficient L-amino acid (CDAA) defined diet-induced liver fibrosis in 16-week-old male Wistar rats [1].
  • They show HOE 077 to be a promising agent for the inhibition of hepatic fibrosis [2].
 

High impact information on HOE 077

 

Chemical compound and disease context of HOE 077

  • BACKGROUND/AIMS: The aim of this study was to investigate the effect and mechanism of fibrosuppression by a newly synthesized prolyl 4-hydroxylase inhibitor [HOE 077, 2, 4-pyridine dicarboxylic acid bis [(2-methoxyethyl) amide]] on pig serum-induced liver fibrosis in the rat [7].
 

Biological context of HOE 077

 

Anatomical context of HOE 077

 

Gene context of HOE 077

  • We have demonstrated that antifibrotic agents, such as HOE 077, TJ-9 and interferon, can reduce the risk of HCC [11].
 

Analytical, diagnostic and therapeutic context of HOE 077

References

  1. The prolyl 4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline-deficient L-amino acid-defined diet. Sakaida, I., Matsumura, Y., Kubota, M., Kayano, K., Takenaka, K., Okita, K. Hepatology (1996) [Pubmed]
  2. Fibrosis of the liver in rats induced by bile duct ligation. Effects of inhibition by prolyl 4-hydroxylase. Böker, K., Schwarting, G., Kaule, G., Günzler, V., Schmidt, E. J. Hepatol. (1991) [Pubmed]
  3. Two novel antifibrotics, HOE 077 and Safironil, modulate stellate cell activation in rat liver injury: differential effects in males and females. Wang, Y.J., Wang, S.S., Bickel, M., Guenzler, V., Gerl, M., Bissell, D.M. Am. J. Pathol. (1998) [Pubmed]
  4. Prevention of fibrosis reduces enzyme-altered lesions in the rat liver. Sakaida, I., Kubota, M., Kayano, K., Takenaka, K., Mori, K., Okita, K. Carcinogenesis (1994) [Pubmed]
  5. Beneficial effects of inhibitors of prolyl 4-hydroxylase in CCl4-induced fibrosis of the liver in rats. Bickel, M., Baader, E., Brocks, D.G., Engelbart, K., Günzler, V., Schmidts, H.L., Vogel, G.H. J. Hepatol. (1991) [Pubmed]
  6. Pharmacokinetics and metabolism of HOE 077. Preclinical studies. Kellner, H.M., Volz, M., Badder, E., Kürzel, G.U., Eckert, H.G. J. Hepatol. (1991) [Pubmed]
  7. Prolyl 4-hydroxylase inhibitor (HOE 077) inhibits pig serum-induced rat liver fibrosis by preventing stellate cell activation. Matsumura, Y., Sakaida, I., Uchida, K., Kimura, T., Ishihara, T., Okita, K. J. Hepatol. (1997) [Pubmed]
  8. General pharmacology, toxicology and future clinical development of HOE 077. Horn, W. J. Hepatol. (1991) [Pubmed]
  9. Prolyl 4-hydroxylase inhibitor (HOE 077) prevents TIMP-1 gene expression in rat liver fibrosis. Sakaida, I., Uchida, K., Hironaka, K., Okita, K. J. Gastroenterol. (1999) [Pubmed]
  10. Failure of a prolyl 4-hydroxylase inhibitor to alter extracellular matrix deposition during experimental pancreatitis. Weidenbach, H., Lerch, M.M., Turi, S., Bachem, M., Adler, G. Digestion (1997) [Pubmed]
  11. Current strategies for chemoprevention of hepatocellular carcinoma. Okita, K., Sakaida, I., Hino, K. Oncology (2002) [Pubmed]
 
WikiGenes - Universities